Rotunda Hospital
- Address
- lock Available on a paid plan
Female Urogenital and Pregnancy-Related Research
At Rotunda Hospital, clinical research in female urogenital diseases and pregnancy complications focuses on improving outcomes for women with antiphospholipid antibodies and related obstetric risks. These studies are designed to assess whether targeted treatments can support healthier pregnancies and reduce complications.
- Evaluating treatment effectiveness in women with antiphospholipid antibodies
- Studying approaches to improve pregnancy outcomes
- Exploring therapies for immune-related obstetric complications
This work also connects with broader immune system disease research, reflecting the site’s interest in conditions where maternal health and fetal wellbeing are closely linked.
Fetal and Newborn Blood Disorders
Research in hemolytic disease of the fetus and newborn is a major focus at the Rotunda Private Clinics. The trials aim to test new ways to reduce the risk of fetal anemia and improve survival and health outcomes for babies affected by severe antibody-mediated disease during pregnancy.
- Testing a new therapy for severe fetal anemia risk
- Improving care for pregnancies affected by HDFN
- Assessing strategies to support live birth outcomes
This area sits at the intersection of pregnancy complications and immune-mediated disease, with a strong emphasis on protecting both mother and baby.
Newborn Neurology and Brain Injury
The site also supports studies in nervous system diseases, including moderate-severe hypoxic-ischaemic encephalopathy in newborns. These trials are focused on evaluating whether emerging treatments can better protect the infant brain and improve early recovery after oxygen-related injury at birth.
- Testing a potential therapy for newborn encephalopathy
- Assessing safety and tolerability in acute neonatal care
- Exploring ways to improve neurological outcomes
This research reflects a strong commitment to advancing care for critically ill newborns through neonatal medicine and brain-protective treatment strategies.
Cardiovascular and Neonatal Circulatory Care
Clinical trials in cardiovascular diseases at Rotunda Hospital include work on patent ductus arteriosus in extremely premature infants. The research is aimed at improving treatment effectiveness and reducing complications linked to duct-related heart problems in very small babies.
- Comparing treatment approaches for PDA in premature infants
- Testing a combination therapy to improve duct-related outcomes
- Seeking better ways to lower serious neonatal complications
These studies are part of a wider effort to refine neonatal cardiovascular care and support healthier early-life outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Janssen Cilag International1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 45 other sites in Ireland
Therapeutic Area Benchmark — Ireland
Select a therapeutic area to compare against other sites in Ireland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Ireland
Market Share
Country: Ireland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Rotunda Hospital
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN). | Janssen Cilag International | Phase III | Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | 1 | Unknown | 2023-06-27 | 2023-06-27 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.